NAD Takes Issue With University Medical WrinkleFree Claims...Again
This article was originally published in The Rose Sheet
Performance claims from University Medical Pharmaceuticals touting the quick-acting effect of its WrinkleFree Eyes and comparing the product to Botox should be discontinued, the National Advertising Division says
You may also be interested in...
The National Advertising Review Board upholds a NAD ruling that the brand should discontinue claims comparing its Plantscription anti-aging serum to anti-wrinkle prescription products. NARB reversed several other NAD decisions on certain claims for the same product.
The Estee Lauder Companies’ Origins unit is appealing to NARB after NAD advised the firm to drop or modify claims comparing its Plantscription products to anti-aging prescription cream Renova.
University Medical Pharmaceuticals continues to have trouble supporting its product claims to the satisfaction of the National Advertising Division